Dysregulation of miR-193a serves as a potential contributor to MS pathogenesis via affecting RhoA and Rock1

Nasim Saeidi1, Hadi Goudarzvand2, Hamed Mohammadi3

  • 1DNA Laboratory, Analytical Laboratories, Hamilton, New Zealand.

Abstract

Insights

Reduced miR-193a levels in multiple sclerosis (MS) patients correlate with increased RhoA and ROCK1 expression, indicating potential as a diagnostic and therapeutic biomarker for MS.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease.
  • MicroRNAs (miRNAs) are key regulators and potential biomarkers for diseases.
  • Identifying novel biomarkers for MS early detection and treatment is crucial.

Purpose of the Study:

  • To investigate the role of miR-193a in multiple sclerosis (MS).
  • To explore miR-193a as a potential diagnostic and prognostic biomarker for MS.
  • To assess miR-193a's therapeutic potential in MS.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) and Western blotting were used to assess miR-193a, RhoA, and ROCK1 expression in MS patients.
  • miR-193a mimic transfection was performed in MS-derived peripheral blood mononuclear cells (PBMCs).
  • Correlation analysis between miR-193a levels and clinicopathological features was conducted.

Main Results:

  • miR-193a expression was significantly decreased in MS patients' PBMCs compared to controls.
  • RhoA and ROCK1 expression levels were elevated in MS patients and reduced upon miR-193a transfection.
  • Down-regulation of miR-193a correlated with increased C-reactive protein (CRP), cerebrospinal fluid (CSF) IgG positivity, and Multiple Sclerosis Severity Score (MSSS).

Conclusions:

  • miR-193a down-regulation modulates RhoA and ROCK1 expression in MS, contributing to disease progression.
  • miR-193a and its targets (RhoA, ROCK1) show promise as diagnostic, prognostic, and therapeutic targets for MS.
  • This study highlights miR-193a as a potential non-invasive biomarker for MS.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
2.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K